SI
ABMD

Stephens Inc’s Abiomed Inc ABMD Stock Holding History

Stephens Inc’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,263
Closed -$1.54M – 1257
2022
Q3 		$1.54M Sell
6,263
-230
-4% -$62.1K 0.03% 421
2022
Q2 		$1.61M Sell
6,493
-407
-6% -$110K 0.03% 427
2022
Q1 		$2.29M Sell
6,900
-60
-0.9% -$18.5K 0.04% 400
2021
Q4 		$2.5M Sell
6,960
-50
-0.7% -$16.9K 0.04% 407
2021
Q3 		$2.28M Sell
7,010
-17
-0.2% -$5.76K 0.04% 438
2021
Q2 		$2.19M Buy
7,027
+19
+0.3% +$5.83K 0.03% 457
2021
Q1 		$2.23M Sell
7,008
-736
-10% -$236K 0.04% 438
2020
Q4 		$2.51M Sell
7,744
-936
-11% -$259K 0.05% 371
2020
Q3 		$2.4M Buy
8,680
+8
+0.1% +$2.31K 0.05% 353
2020
Q2 		$2.1M Sell
8,672
-1,021
-11% -$205K 0.05% 368
2020
Q1 		$1.41M Sell
9,693
-317
-3% -$52.6K 0.04% 404
2019
Q4 		$1.71M Sell
10,010
-226
-2% -$41.9K 0.04% 437
2019
Q3 		$1.82M Sell
10,236
-7,793
-43% -$1.68M 0.04% 405
2019
Q2 		$4.7M Sell
18,029
-1,520
-8% -$403K 0.11% 220
2019
Q1 		$5.58M Sell
19,549
-151
-0.8% -$50.2K 0.13% 173
2018
Q4 		$6.4M Sell
19,700
-1,249
-6% -$434K 0.18% 122
2018
Q3 		$9.42M Buy
+20,949
New +$8.26M 0.23% 97
2017
Q3 		– Sell
-15,541
Closed -$2.23M – 894
2017
Q2 		$2.23M Buy
15,541
+2,294
+17% +$308K 0.08% 271
2017
Q1 		$1.66M Sell
13,247
-535
-4% -$62K 0.06% 327
2016
Q4 		$1.55M Buy
13,782
+1,442
+12% +$167K 0.06% 304
2016
Q3 		$1.59M Sell
12,340
-4,205
-25% -$504K 0.07% 287
2016
Q2 		$1.81M Sell
16,545
-2,645
-14% -$263K 0.08% 256
2016
Q1 		$1.82M Sell
19,190
-4,185
-18% -$353K 0.09% 241
2015
Q4 		$2.11M Buy
23,375
+3,918
+20% +$332K 0.11% 202
2015
Q3 		$1.8M Buy
19,457
+5,816
+43% +$512K 0.09% 224
2015
Q2 		$897K Buy
13,641
+3,311
+32% +$220K 0.04% 382
2015
Q1 		$739K Sell
10,330
-24,485
-70% -$1.33M 0.03% 423
2014
Q4 		$1.32M Buy
34,815
+25,700
+282% +$811K 0.06% 291
2014
Q3 		$226K Buy
9,115
+200
+2% +$5.07K 0.01% 680
2014
Q2 		$224K Buy
+8,915
New +$207K 0.01% 730

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Stephens Inc's ABMD Position: Q4 2022 in Review

Stephens Inc sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 6,263 shares — an estimated $1.54M sold.

Stephens Inc first reported a position in ABMD in Q2 2014 and held it in 30 quarters. The position peaked at $9.42M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Stephens Inc reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Stephens Inc sold 6,263 Abiomed Inc shares in Q4 2022, an estimated $1.54M.
  • Stephens Inc first reported a position in Abiomed Inc in Q2 2014 and held it in 30 quarters.
  • Stephens Inc's Abiomed Inc position peaked at $9.42M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Stephens Inc's 13F filing for Q4 2022, filed 25 Jan 2023.